Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

ergometrine/illamående

Länken sparas på Urklipp
ArtiklarKliniska testerPatent
Sida 1 från 26 resultat

Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND The routine prophylactic administration of an uterotonic agent is an integral part of active management of the third stage of labour, helping to prevent postpartum haemorrhage (PPH). The two most widely used uterotonic agents are: ergometrine-oxytocin (Syntometrine) (a combination of

Ergometrine, oxytocin and extradural analgesia.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Blood loss and the incidence of emetic sequelae were assessed in 148 patients undergoing midcavity forceps delivery under continuous lumbar extradural analgesia. Five units of oxytocin i.v. was found to be as effective as ergometrine 0.5 mg i.v. in reducing blood loss at delivery. Nausea, retching

Where does ergometrine stand in prevention of postpartum haemorrhage in caesarean section?

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE To compare the safety and efficacy of 10 units of intravenous syntocinon alone with 10 units intravenous syntocinon and 0.25 mg intramuscular ergometrine in the prevention of atonic uterine haemorrhage during caesarean section. METHODS The quasi-experimental study was conducted at the

A randomized comparative study of prophylactic oxytocin versus ergometrine in the third stage of labor.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE To compare the effect of prophylactic use of oxytocin and ergometrine in management of the third stage of labor. METHODS A prospective randomized study of 600 women assigned to receive either oxytocin or ergometrine in the third stage of labor. Outcome measures were the predelivery and

Oxytocin-ergometrine co-administration does not reduce blood loss at caesarean delivery for labour arrest.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE To determine if intravenous infusion of a combination of oxytocin and ergometrine maleate is better than oxytocin alone to decrease blood loss at caesarean delivery for labour arrest. METHODS Prospective, double-blinded, randomised controlled trial. METHODS Mount Sinai Hospital, Toronto,
OBJECTIVE To compare oxytocin plus ergometrine against oxytocin alone, when administered as part of the active management of the 3rd stage of labor, in terms of postpartum hemorrhage and manual removal of the placenta. METHODS A double-blind, randomized controlled trial. METHODS A university

Randomised controlled trial of oxytocin alone versus oxytocin and ergometrine in active management of third stage of labour.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE To compare intramuscular oxytocin alone and intramuscular oxytocin with ergometrine (Syntometrine) for their effect in reducing the risk of postpartum haemorrhage when both are used as part of the active management of the third stage of labour. METHODS Double blind, randomised controlled
OBJECTIVE The purpose of the study was to compare the efficacy of misoprostol 400 μg per rectally, injection oxytocin 10 IU intramuscular, injection methylergometrine 0.2 mg intravenously and injection (0.5 mg ergometrine + 5 IU oxytocin) intramuscular on reducing blood loss in third stage of labor,

[Blood loss and nausea during legal abortion].

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The efficiency of oxytocic drugs in therapeutic abortion was studied in 113 women who were randomly assigned to either a control group (n = 44) receiving no oxytocic drugs, a group (n = 36) receiving 0.2 mg ergometrine by slow intravenous injection, or a group (n = 33) given 5 units oxytocin in a

Ergometrine given during caesarean section and incidence of delayed postpartum haemorrhage due to uterine atony.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Delayed postpartum haemorrhage due to uterine atony after caesarean section was occurring in women in our recovery area despite many of them already having an oxytocin infusion running to prevent such a problem. We therefore decided to compare the incidence of such problems for a 2-month period

Prophylactic use of ergot alkaloids in the third stage of labour.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Previous research has shown that the prophylactic use of uterotonic agents in the third stage of labour reduces postpartum blood loss and moderate to severe postpartum haemorrhage (PPH). PPH is defined as a blood loss of 500 mL or more within 24 hours after birth. This is one of a series of

A clinical trial of alfentanil as an adjuvant for short anaesthetic procedures.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Alfentanil 700 micrograms and fentanyl 100 micrograms were compared as anaesthetic adjuvants in 90 patients undergoing short duration gynaecological procedures. The results show that, at the chosen dose ratio, alfentanil causes a higher frequency of post-induction apnoea, but thereafter the

A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
OBJECTIVE Syntometrine is an effective uterotonic agent used in preventing primary postpartum haemorrhage but has adverse effects including nausea, vomiting, hypertension and coronary artery spasm. Carbetocin is a newly developed long-acting oxytocin analogue that might be used as an uterotonic

Safety of ergot stress echocardiography for non-invasive detection of coronary vasospasm.

Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND The safety of ergonovine/ergometrine stress testing for coronary vasospasm when performed outside the cardiac catheterization laboratory (cath lab) has been questioned vigorously. OBJECTIVE To assess the tolerability and safety of ergonovine/ergometrine stress testing performed in the
BACKGROUND The safety of ergonovine/ergometrine stress testing for coronary vasospasm when performed outside the cath lab has vigorously been questioned. The aim of this study was to assess the value of ergonovine/ergometrine stress testing performed in the echo lab. METHODS We retrospectively
Gå med på vår
facebook-sida

Den mest kompletta databasen med medicinska örter som stöds av vetenskapen

  • Fungerar på 55 språk
  • Växtbaserade botemedel som stöds av vetenskap
  • Örter igenkänning av bild
  • Interaktiv GPS-karta - märka örter på plats (kommer snart)
  • Läs vetenskapliga publikationer relaterade till din sökning
  • Sök efter medicinska örter efter deras effekter
  • Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent

Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning

Google Play badgeApp Store badge